|
Name |
1,3,5-Triazine-2,4-diamine
|
Molecular Formula | C3H5N5 | |
IUPAC Name* |
1,3,5-triazine-2,4-diamine
|
|
SMILES |
C1=NC(=NC(=N1)N)N
|
|
InChI |
InChI=1S/C3H5N5/c4-2-6-1-7-3(5)8-2/h1H,(H4,4,5,6,7,8)
|
|
InChIKey |
VZXTWGWHSMCWGA-UHFFFAOYSA-N
|
|
Synonyms |
1,3,5-Triazine-2,4-diamine; 504-08-5; 2,4-Diamino-1,3,5-triazine; Formoguanamine; Guanamine; 4,6-Diamino-s-triazine; Diamino-s-triazine; 2,6-Diamino-s-triazine; 2,4-DIAMINO-S-TRIAZINE; s-Triazine, 2,4-diamino-; NSC 251; A6GN3JB7H4; NSC-251; EINECS 207-983-7; s-Triazine,4-diamino-; AI3-51263; UNII-A6GN3JB7H4; SCHEMBL65511; YSWG323; 1,5-Triazine-2,4-diamine; Fmoc-(3-aminophenyl)aceticacid; NSC251; DTXSID7074292; CHEBI:38071; [1,3,5]Triazine-2,4-diamine; ALBB-014718; ZINC1445475; MFCD00014598; STK256616; AKOS005174532; SB73700; AS-48301; CS-0110380; D2227; FT-0609961; D-2227; EN300-216072; F30229; A871573; Q27117366; ZZS
|
|
CAS | 504-08-5 | |
PubChem CID | 10435 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 111.11 | ALogp: | -0.7 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 90.7 | Aromatic Rings: | 1 |
Heavy Atoms: | 8 | QED Weighted: | 0.472 |
Caco-2 Permeability: | -5.008 | MDCK Permeability: | 0.00070076 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.963 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.028 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.688 | Plasma Protein Binding (PPB): | 9.68% |
Volume Distribution (VD): | 1.005 | Fu: | 74.47% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.219 |
CYP2C19-inhibitor: | 0.051 | CYP2C19-substrate: | 0.031 |
CYP2C9-inhibitor: | 0.007 | CYP2C9-substrate: | 0.003 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.04 |
CYP3A4-inhibitor: | 0.002 | CYP3A4-substrate: | 0.109 |
Clearance (CL): | 2.66 | Half-life (T1/2): | 0.929 |
hERG Blockers: | 0.049 | Human Hepatotoxicity (H-HT): | 0.999 |
Drug-inuced Liver Injury (DILI): | 0.963 | AMES Toxicity: | 0.702 |
Rat Oral Acute Toxicity: | 0.555 | Maximum Recommended Daily Dose: | 0.024 |
Skin Sensitization: | 0.931 | Carcinogencity: | 0.708 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.957 |
Respiratory Toxicity: | 0.921 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000011 | 0.308 | D08IBS | 0.308 | ||||
ENC000467 | 0.209 | D03FLC | 0.222 | ||||
ENC000635 | 0.190 | D02ZXM | 0.205 | ||||
ENC000599 | 0.189 | D06QKV | 0.203 | ||||
ENC002667 | 0.182 | D0X5XU | 0.200 | ||||
ENC000577 | 0.175 | D06HCP | 0.197 | ||||
ENC001225 | 0.167 | D0AO5H | 0.194 | ||||
ENC000728 | 0.163 | D0D9HW | 0.194 | ||||
ENC000721 | 0.159 | D09FAZ | 0.193 | ||||
ENC001351 | 0.156 | D0NI0C | 0.190 |